Hoxton Financial’s AbbVie ABBV Stock Holding History

Hoxton Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$45K	Buy	792 +95	+14%	+$5.29K	0.02%	149
2015 Q4	$41K	Sell	697 -345	-33%	-$19.9K	0.02%	144
2015 Q3	$57K	Hold	1,042	–	–	0.03%	130
2015 Q2	$70K	Hold	1,042	–	–	0.03%	120
2015 Q1	$61K	Hold	1,042	–	–	0.03%	130
2014 Q4	$68K	Hold	1,042	–	–	0.03%	130
2014 Q3	$60K	Sell	1,042 -55	-5%	-$3.05K	0.03%	124
2014 Q2	$62K	Hold	1,097	–	–	0.03%	123
2014 Q1	$56K	Sell	1,097 -158	-13%	-$7.99K	0.02%	125
2013 Q4	$66K	Buy	1,255 +246	+24%	+$12.1K	0.03%	192
2013 Q3	$45K	Sell	1,009 -45	-4%	-$2K	0.04%	129
2013 Q2	$44K	Buy	+1,054	New	+$46.1K	0.02%	208

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Hoxton Financial's ABBV Position: Q1 2016 in Review

Hoxton Financial increased its AbbVie (ABBV) stake by 14% in Q1 2016, buying an estimated $5.29K and bringing the position to 792 shares worth $45K. The position accounts for 0.02% of the portfolio, ranked #149.

Hoxton Financial first reported a position in ABBV in Q2 2013 and has held it in 12 quarters since. The position peaked at $70K in Q2 2015. 1,639 funds tracked by Wall St. Rank hold ABBV as of Q1 2016.

Hoxton Financial held 792 shares of AbbVie worth $45K as of Q1 2016.
Hoxton Financial bought 95 AbbVie shares in Q1 2016, an estimated $5.29K.
AbbVie made up 0.02% of Hoxton Financial's portfolio in Q1 2016, its #149 holding.
Hoxton Financial first reported a position in AbbVie in Q2 2013 and has held it in 12 quarters since.
Hoxton Financial's AbbVie position peaked at $70K in Q2 2015.
1,639 funds tracked by Wall St. Rank held AbbVie as of Q1 2016.

Based on Hoxton Financial's 13F filing for Q1 2016, filed 29 Apr 2016.